You are viewing: France Elastomeric Infusion Pumps Market analysis

The France Elastomeric Infusion Pumps Market was valued at $38.3 Million in 2025 and projected to reach to $49.5 Million by 2030, representing a compound annual growth rate of 5.3%. France's elastomeric infusion pumps market demonstrates resilient growth driven by increasing prevalence of chronic diseases, aging population demographics, and rising preference for patient-centric portable delivery systems.

France Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Elastomeric Infusion Pumps Market Trends and Insights

  • France maintains a strategic position within Europe's medical device landscape, driven by robust healthcare infrastructure and increasing adoption of portable infusion delivery systems.
  • The French market benefits from strong regulatory frameworks and growing demand for patient-centric, ambulatory care solutions across oncology, pain management, and chronic disease treatment segments. During the 2025–2030 forecast period, France is expected to experience steady market expansion fueled by technological advancements in elastomeric pump design, rising prevalence of chronic conditions, and healthcare provider preference for cost-effective infusion alternatives.
  • France's aging population and emphasis on home-based healthcare delivery further support market growth.
  • The country's established pharmaceutical and medical device sectors create favorable conditions for elastomeric infusion pump adoption among hospitals, clinics, and home healthcare providers..

Key Market Statistics

  • CAGR (2025-2030) 5.3% CAGR
  • Market Size, 2025 ~USD 38.3 Million
  • Forecast, 2030 ~USD 49.5 Million
  • Country France

France Elastomeric Infusion Pumps Market Overview

Market Valuation :

France's elastomeric infusion pumps market is valued at USD 38.3 million in 2025, with steady growth trajectory positioning it as a significant contributor to European medical device innovation.

Healthcare Infrastructure :

France's advanced healthcare system and high medical device adoption rates drive demand for portable infusion delivery solutions across hospitals, clinics, and home care settings.

Growth Momentum :

The French market is projected to reach USD 49.5 million by 2030, reflecting a consistent 5.3% CAGR aligned with global market expansion trends in elastomeric infusion technology.

Regulatory Environment :

France's compliance with EU medical device regulations (MDR) and CE marking requirements ensures high-quality product standards, fostering market confidence and competitive differentiation.

France Elastomeric Infusion Pumps Market Dynamics

  • The French healthcare sector's emphasis on cost-effective treatment solutions and home-based care models accelerates adoption of elastomeric infusion technology across oncology, pain management, and antibiotic therapy applications. Looking ahead to 2030, France's market expansion will be supported by continuous innovation in pump design, enhanced biocompatibility materials, and integration with digital health platforms.
  • Strategic partnerships between French medical device manufacturers and healthcare providers, combined with favorable reimbursement policies, will strengthen market penetration and create opportunities for both established players and emerging innovators in the elastomeric infusion pump segment..

Related Ecosystem

Key Takeaways

  • France's elastomeric infusion pumps market is valued at USD 38.3 million in 2025 and will reach USD 49.5 million by 2030, growing at 5.3% CAGR.
  • France's robust healthcare infrastructure and regulatory environment support steady adoption of elastomeric infusion systems across clinical and home care settings.
  • Aging demographics and shift toward ambulatory care in France drive demand for portable, cost-effective infusion delivery solutions.
  • France's established pharmaceutical and medical device sectors create competitive advantages for elastomeric pump manufacturers and distributors.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

France Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030

Segment20232024202520262027202820292030CAGR (%)
AMBULATORY SURGICAL CENTERS (ASCS)9.49.810.310.911.512.212.813.55.5
HOMECARE SETTINGS8.48.89.39.910.511.111.812.55.9
HOSPITALS14.915.516.21717.918.719.720.64.9
OTHER END-USE INDUSTRIES2.12.22.32.42.62.72.82.94.8
TOTAL34.836.338.340.342.444.74749.55.3

Target Audience

  • Medical Device Manufacturers : Manufacturers seeking to expand or establish presence in France need detailed market sizing, competitive positioning, and regulatory pathway information to optimize product launches and market penetration strategies.
  • Healthcare System Administrators : French hospital networks and healthcare providers require market data to evaluate infusion pump procurement decisions, budget planning, and technology adoption aligned with clinical outcomes and cost-effectiveness.
  • Investment & Private Equity Firms : Investors evaluating opportunities in French medical device companies need comprehensive market forecasts, growth drivers, and competitive analysis to assess investment viability and portfolio returns.
  • Distributors & Suppliers : Medical device distributors operating in France require market intelligence on demand trends, customer segments, and growth projections to optimize inventory, sales strategies, and partnership development.
  • Regulatory & Compliance Consultants : Consultants advising companies on French market entry need detailed regulatory landscape, reimbursement policies, and healthcare system requirements to guide clients through compliance and commercialization processes.

Key Companies in the France Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Market-Specific Sizing : Access precise valuation data for France's elastomeric infusion pumps market with detailed 2025-2030 forecasts, enabling accurate budget allocation and revenue projections for French operations.
  • Competitive Landscape Intelligence : Understand France-specific competitive dynamics, key market players, and differentiation strategies tailored to French healthcare regulations and reimbursement frameworks.
  • Regulatory & Compliance Insights : Gain comprehensive understanding of French and EU regulatory requirements, CE marking pathways, and healthcare system nuances critical for market entry and product positioning.
  • Growth Opportunity Identification : Identify high-potential segments within France's market including oncology, pain management, and home care applications with specific adoption rates and expansion drivers.
  • Strategic Decision Support : Leverage France-focused market intelligence for partnership development, distribution channel optimization, and investment decisions in the European elastomeric infusion pump sector.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in France?

France's elastomeric infusion pumps market is valued at USD 38.3 million in 2025.

What is the projected market size for elastomeric infusion pumps in France by 2030?

France's elastomeric infusion pumps market is projected to reach USD 49.5 million by 2030.

What is the growth rate of the elastomeric infusion pumps market in France?

France's elastomeric infusion pumps market is expected to grow at a compound annual growth rate of 5.3% from 2025 to 2030.

What factors are driving growth in France's elastomeric infusion pumps market?

Key drivers include France's aging population, shift toward home-based healthcare, technological advancements in pump design, and healthcare provider preference for cost-effective infusion solutions.

Which application segments dominate France's elastomeric infusion pumps market?

France's elastomeric infusion pumps are primarily used in oncology, pain management, and chronic disease treatment, with growing adoption in ambulatory and home healthcare settings.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status